Ropivacaine as a Novel AKT1 Specific Inhibitor Regulates the Stemness of Breast Cancer

The effects of ropivacaine on breast cancer stemness were investigated by in vitro and in vivo assays. The authors reported that ropivacaine suppressed stem cell-like properties of breast cancer cells.